Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Bogdahn

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Oncology Reports|November 18, 2004
Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade gliomaPeter Hau, Petra Ruemmele, Leoni A Kunz-Schughart, et al.
Stem Cells (Dayton, Ohio)|November 8, 2008
A nuclear magnetic resonance biomarker for neural progenitor cells: is it all neurogenesis?Paul Ramm, Sebastien Couillard-Despres, Sonja Plötz, et al.
Neurology Research International|July 23, 2015
Inventory of a Neurological Intensive Care Unit: Who Is Treated and How Long?Roland Backhaus, Franz Aigner, Felix Schlachetzki, et al.
Plos One|September 3, 2011
Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trialSandra Boy, Sophie Sauerbruch, Mathias Kraemer, et al.
Journal of Neuro-Oncology|June 4, 2004
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II studyCaecilia Wismeth, Peter Hau, Klaus Fabel, et al.
Journal of Neuro-Oncology|December 25, 2009
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical resultsCaecilia Wismeth, Christine Dudel, Christina Pascher, et al.
Journal of Neuro-Oncology|November 18, 2005
Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomasPeter Hau, Leoni A Kunz-Schughart, Petra Rümmele, et al.
Oncotarget|December 29, 2016
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylationVerena Leidgens, Judith Proske, Lisa Rauer, et al.
Plos One|November 14, 2013
Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitroCorinna Seliger, Petra Leukel, Sylvia Moeckel, et al.
Journal of Neurochemistry|January 25, 2005
Neuronal precursor-specific activity of a human doublecortin regulatory sequenceClaudia Karl, Sebastien Couillard-Despres, Peter Prang, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Oncology Reports|November 18, 2004
Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade gliomaPeter Hau, Petra Ruemmele, Leoni A Kunz-Schughart, et al.
Stem Cells (Dayton, Ohio)|November 8, 2008
A nuclear magnetic resonance biomarker for neural progenitor cells: is it all neurogenesis?Paul Ramm, Sebastien Couillard-Despres, Sonja Plötz, et al.
Neurology Research International|July 23, 2015
Inventory of a Neurological Intensive Care Unit: Who Is Treated and How Long?Roland Backhaus, Franz Aigner, Felix Schlachetzki, et al.
Plos One|September 3, 2011
Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trialSandra Boy, Sophie Sauerbruch, Mathias Kraemer, et al.
Journal of Neuro-Oncology|June 4, 2004
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II studyCaecilia Wismeth, Peter Hau, Klaus Fabel, et al.
Journal of Neuro-Oncology|December 25, 2009
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical resultsCaecilia Wismeth, Christine Dudel, Christina Pascher, et al.
Journal of Neuro-Oncology|November 18, 2005
Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomasPeter Hau, Leoni A Kunz-Schughart, Petra Rümmele, et al.
Oncotarget|December 29, 2016
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylationVerena Leidgens, Judith Proske, Lisa Rauer, et al.
Plos One|November 14, 2013
Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitroCorinna Seliger, Petra Leukel, Sylvia Moeckel, et al.
Journal of Neurochemistry|January 25, 2005
Neuronal precursor-specific activity of a human doublecortin regulatory sequenceClaudia Karl, Sebastien Couillard-Despres, Peter Prang, et al.
Pageof 16